ABT Abbott Laboratories

Five-factor quant read, peer ranking, and the analyst team's own call.

6.7
composite/ 10
Value computed
3.3

priced for 9.6% growth vs 0.5% delivered · -39% to base-case fair value

Quality computed
7.0

Piotroski 5/8 · Altman safe zone · ROE 12% · interest covered 18x

Momentum rank
5.0

low-beta - defensive profile · strong 3-month run

Defensive rank
10.0
Tactical rank
8.0

Descriptive, not predictive. Momentum, Defensive and Tactical are deciles within our liquid universe; Value and Quality are computed from filed financials. None of them forecasts a return - the model's out-of-sample AUC is published in the whitepaper. Deciles as of 2026-09-02.

Peer comparison

Composite score against sector peers · 6 names

#1
8.4
#2
6.9
#3
6.7
#4
6.7
#5
6.7
#6
4.6

ABT ranks #3 of 6 · peer average 6.7

No current desk call on ABT. The factor scores above are computed; a full analysis is four analyst desks, a bull-vs-bear debate and a risk committee, and takes about three minutes.

Automated, educational research - not investment advice, and not a recommendation to buy or sell any security.